Price T Rowe (TROW) director receives 1,899-share stock award grant

Rhea-AI Filing Summary

DUBLON DINA reported acquisition or exercise transactions in this Form 4 filing.

Price T Rowe Group director Dina Dublon received 1,899 shares of restricted common stock as a grant under the 2017 Non-Employee Director Equity Plan. The award is valued at $105.33 per share and vests in full by the next annual meeting or earlier upon death, total and permanent disability, or a change in control. After this grant, she holds 15,424.4541 shares directly and 1,890 shares indirectly through The Dina Dublon Family Trust.

Insights

Equity compensation analyst

Routine director equity grant with time-based vesting and no open-market trading.

Dina Dublon, a director of Price T Rowe Group, received 1,899 restricted shares under the 2017 Non-Employee Director Equity Plan at a reference value of $105.33 per share. This is compensation, not an open-market purchase.

The shares and accrued dividends vest in full upon the earlier of the next annual meeting, death, total and permanent disability, or a change in control, as described in the award terms. This creates a straightforward, time-based incentive aligned with continued board service.

Following the grant, Dublon holds 15,424.4541 shares directly and 1,890 shares indirectly via The Dina Dublon Family Trust, indicating a modest equity stake. With no reported open-market buys or sells in this filing, the transactions appear to be routine director compensation rather than a signal about the company’s valuation.

Insider Trade Summary

Net Buyer: 1,899 shares

Net Buy 2 txns

Insider DUBLON DINA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,899	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 15,424.4541 shares (Direct); Common Stock — 1,890 shares (Indirect, The Dina Dublon Family Trust)

Footnotes (1)

1. F1. Pursuant to the 2017 Non-Employee Director Equity Plan, this restricted Award Shares was issued at $105.33 share, the closing price of TROW shares on May 8, 2026. The forfeiture provisions of the Award Shares and all accrued dividends attributed to such Award Shares, will vest in full and become nonforfeitable upon the earliest of the following dates: (a) the day immediately prior to the Annual Meeting that occurs in the next calendar year following the year in which the Award Shares were granted as reflected on the Notice, (b) date of death, (c) the date on which it has been determined that the award holder suffered, a Total and Permanent Disability, or (d) the date on which a Change in Control occurs, in which case the vesting will take place immediately before and contingent upon the occurrence of the Change in Control.

Key Figures

Restricted shares granted: 1,899 shares Award share value: $105.33 per share Direct holdings after grant: 15,424.4541 shares +1 more

4 metrics

Restricted shares granted 1,899 shares Non-Employee Director Equity Plan award on May 8, 2026

Award share value $105.33 per share Closing TROW price on May 8, 2026 for grant

Direct holdings after grant 15,424.4541 shares Common stock held directly following Form 4 transactions

Indirect trust holdings 1,890 shares Common stock held via The Dina Dublon Family Trust

Key Terms

2017 Non-Employee Director Equity Plan, restricted Award Shares, Total and Permanent Disability, Change in Control

4 terms

2017 Non-Employee Director Equity Plan financial

"Pursuant to the 2017 Non-Employee Director Equity Plan, this restricted Award Shares was issued..."

restricted Award Shares financial

"this restricted Award Shares was issued at $105.33 share, the closing price of TROW shares..."

Total and Permanent Disability financial

"the date on which it has been determined that the award holder suffered, a Total and Permanent Disability..."

Change in Control financial

"the date on which a Change in Control occurs, in which case the vesting will take place immediately before..."

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 05/11/2026 - 03:34 PM Learn about SEC filing dates

FAQ

What insider transaction did Price T Rowe (TROW) director Dina Dublon report?

Dina Dublon reported receiving 1,899 restricted shares of Price T Rowe common stock as a grant under the 2017 Non-Employee Director Equity Plan. This was an equity compensation award, not an open-market purchase or sale, and increased her direct share holdings.

At what price were Dina Dublon’s restricted shares valued in the TROW Form 4?

The restricted shares were issued at a value of $105.33 per share, equal to the closing price of TROW shares on May 8, 2026. This reference price is used for the award but does not represent cash paid by the director for the shares.

When do Dina Dublon’s 1,899 restricted TROW shares vest?

The 1,899 restricted shares and related dividends vest in full on the day before the next year’s annual meeting, or earlier if she dies, becomes totally and permanently disabled, or if a change in control occurs, with vesting immediately before that change in control event.

How many Price T Rowe (TROW) shares does Dina Dublon hold after this Form 4?

After the reported transactions, Dina Dublon holds 15,424.4541 shares of Price T Rowe common stock directly and 1,890 shares indirectly through The Dina Dublon Family Trust. These positions reflect her equity stake as a non-employee director receiving stock-based compensation.

Does the Form 4 show Dina Dublon buying or selling TROW shares on the market?

The Form 4 does not show any open-market buying or selling by Dina Dublon. It reports a grant of 1,899 restricted shares at no cash cost to her and an indirect holding entry for 1,890 shares in The Dina Dublon Family Trust, both non-market transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DUBLON DINA

(Last) (First) (Middle)

C/O T. ROWE PRICE GROUP, INC.

1307 POINT STREET

(Street)

BALTIMORE MARYLAND 21231

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRICE T ROWE GROUP INC [ TROW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/08/2026		A		1,899(1)	A	$0.00	15,424.4541	D
Common Stock								1,890	I	The Dina Dublon Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to the 2017 Non-Employee Director Equity Plan, this restricted Award Shares was issued at $105.33 share, the closing price of TROW shares on May 8, 2026. The forfeiture provisions of the Award Shares and all accrued dividends attributed to such Award Shares, will vest in full and become nonforfeitable upon the earliest of the following dates: (a) the day immediately prior to the Annual Meeting that occurs in the next calendar year following the year in which the Award Shares were granted as reflected on the Notice, (b) date of death, (c) the date on which it has been determined that the award holder suffered, a Total and Permanent Disability, or (d) the date on which a Change in Control occurs, in which case the vesting will take place immediately before and contingent upon the occurrence of the Change in Control.

Remarks:

	Cheryl L. Emory, Assistant Corporate Secretary, POA for Dublon, Dina	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)